What is the appropriate evaluation and treatment for a 15-year-old male with exercise‑induced dyspnea suggestive of asthma?

Evaluation and Management of Exercise-Induced Dyspnea in a 15-Year-Old Male

Begin with spirometry, bronchodilator reversibility testing, and FeNO measurement as first-line diagnostic tests—do not start treatment based on symptoms alone or conduct empiric therapeutic trials. 1

Diagnostic Approach

Initial Objective Testing (Required Before Treatment)

The European Respiratory Society guidelines emphasize that asthma diagnosis in children aged 5-16 years requires at least two abnormal objective test results 1. For this 15-year-old with exercise-induced symptoms:

Step 1: Perform baseline spirometry

• If FEV1 or FEV1/FVC is below the lower limit of normal (or <80% predicted), proceed to bronchodilator reversibility (BDR) testing
• If spirometry is normal, proceed directly to FeNO measurement 1

Step 2: Interpret results systematically

• BDR positive (≥12% and/or ≥200 mL improvement): Measure FeNO to confirm asthma
• FeNO ≥25 ppb: Asthma confirmed 1
• FeNO <25 ppb with normal spirometry: Asthma is unlikely; consider alternative diagnoses

When Exercise Challenge Testing Is Needed

If initial testing (spirometry, BDR, FeNO) fails to confirm asthma but clinical suspicion remains high, perform an exercise challenge test or surrogate testing 2. This is particularly important because:

• Exercise-induced dyspnea in adolescents is frequently misattributed to asthma when other causes are present 3, 4
• Studies show that in children referred for exercise-induced symptoms, the final diagnosis differs from the referring diagnosis in 54% of cases 3

Exercise challenge specifications 2:

• Ensure heart rate reaches and sustains ≥95% of maximum in children and adolescents
• Use dry medical grade air with ventilation ≥60% of maximum voluntary ventilation
• A ≥10-15% decrease in FEV1 post-exercise confirms exercise-induced bronchoconstriction

Critical Differential Diagnoses to Consider

Do not assume asthma if the patient fails to respond to pre-exercise bronchodilator treatment. 2, 4 Alternative diagnoses include:

1. Exercise-induced laryngeal obstruction (EILD): Requires flexible laryngoscopy during exercise for definitive diagnosis 2
2. Dysfunctional breathing patterns: Identified through cardiopulmonary exercise testing 2
3. Poor cardiovascular conditioning: Normal physiologic limitation 4
4. Chest wall restrictive abnormalities 2

Cardiopulmonary exercise testing is recommended when exercise-induced dyspnea and hyperventilation are suspected to be masquerading as asthma, especially in adolescents 2. This monitors oxygen consumption, CO2 production, end-tidal pCO2, and ECG to differentiate true bronchoconstriction from other causes 5.

Treatment Approach (Only After Confirmed Diagnosis)

For Confirmed Exercise-Induced Bronchoconstriction

First-line pharmacologic management:

• Intermittent pre-exercise SABA (<4 times per week): Provides 2-4 hours of protection 2
• Avoid daily SABA or LABA monotherapy: This leads to tolerance with reduced duration and magnitude of protection 2

For persistent symptoms requiring daily therapy:

• Inhaled corticosteroids (ICS): Decreases frequency and severity of exercise-induced bronchoconstriction 2
• Leukotriene receptor antagonists: Can be used daily without tolerance development; effective in 50% of patients but provides incomplete protection 2
• ICS-LABA combination therapy: Only if underlying persistent asthma is confirmed; not for isolated exercise-induced symptoms with normal baseline lung function 2

Important Caveats

Tolerance development warning: Daily use of β2-agonists (alone or combined with ICS) causes tolerance manifested as reduced bronchoprotection duration and prolonged recovery time 2. This is a critical pitfall—patients using daily SABAs may paradoxically experience worsening exercise tolerance.

Non-pharmacologic adjuncts:

• Pre-exercise warm-up routines reduce EIB severity 2
• Face masks to humidify inspired air can attenuate symptoms 2

Common Pitfalls to Avoid

1. Starting treatment without objective confirmation: Empiric trials where symptom improvement alone confirms diagnosis are explicitly not recommended 1
2. Assuming all exercise dyspnea is asthma: Studies show only 9% of children with exercise-induced dyspnea actually have exercise-induced asthma when properly evaluated 4
3. Missing laryngeal obstruction: This mimics asthma but requires completely different management (speech therapy, not bronchodilators) 2
4. Over-relying on patient/parent report: Objective testing is mandatory because symptom reporting has poor diagnostic accuracy 1, 3